Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Intangibles (2023 - 2025)

Treace Medical Concepts (TMCI) has disclosed Intangibles for 3 consecutive years, with $7.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Intangibles fell 11.76% year-over-year to $7.1 million, compared with a TTM value of $7.1 million through Dec 2025, down 11.76%, and an annual FY2025 reading of $7.1 million, down 11.76% over the prior year.
  • Intangibles was $7.1 million for Q4 2025 at Treace Medical Concepts, down from $7.4 million in the prior quarter.
  • Across five years, Intangibles topped out at $9.5 million in Q2 2023 and bottomed at $7.1 million in Q4 2025.
  • Average Intangibles over 3 years is $8.3 million, with a median of $8.3 million recorded in 2024.
  • The sharpest move saw Intangibles decreased 10.0% in 2024, then dropped 11.76% in 2025.
  • Year by year, Intangibles stood at $9.0 million in 2023, then decreased by 10.53% to $8.1 million in 2024, then fell by 11.76% to $7.1 million in 2025.
  • Business Quant data shows Intangibles for TMCI at $7.1 million in Q4 2025, $7.4 million in Q3 2025, and $7.6 million in Q2 2025.